IGEL said a planned investment by Vitruvian Partners values the endpoint software company at more than $1 billion, adding to its backing from TA Associates as it pursues growth and international expansion.
Funds managed or advised by Vitruvian will invest alongside TA, IGEL said. The company did not disclose the investment amount or either investor’s ownership stake. IGEL expects the transaction to close in the first quarter of 2027, subject to regulatory approvals.
IGEL provides software for administering and protecting the devices employees use to connect to company systems. The company says its platform also supports business continuity and disaster recovery, and serves operational technology environments. IGEL said the investment will support innovation, growth and international expansion, but did not provide a breakdown of how the funds will be used.
IGEL reported that annual recurring revenue grew more than 40% over the past year. The company gave neither a revenue total nor the specific 12-month period measured. TA first invested in IGEL in 2021 and is continuing its backing, according to the company.
IGEL said customers’ focus on secure access, resilience and reliable operations is growing as they update desktop and industrial technology. CEO Klaus Oestermann said enterprises and governments need endpoint technology that helps keep operations running during disruptions. Vitruvian partner Jack Alcock said companies increasingly view immutable endpoints as part of their Zero Trust strategies.
IGEL’s English-language announcement puts the valuation above $1 billion. A French-language release gives a figure above €1 billion, a discrepancy the English announcement does not explain.
The transaction is expected to close in the first quarter of 2027, pending regulatory approvals.



